NewsBenzingaHC Wainwright & Co. riafferma l'acquisto su Praxis Precision Medicine, conferma il target di prezzo di $1201 HC Wainwright & Co. riafferma l'acquisto su Praxis Precision Medicine, conferma il target di prezzo di $1201 Benzinga 2026.09.24 10:26 (GMT+0) Open on Benzinga Other news Rodman & Renshaw Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $70 What's Going On With Oracle Stock Thursday? Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields 'Europe’s Diesel Prices Race Ahead of US on Export-Ban Risks' - Bloomberg Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target LinkedIn Co-Founder Backs Local Control Over Data Center Development: 'Communities That Will Live Alongside a Data center...'
Rodman & Renshaw Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $70
Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields
LinkedIn Co-Founder Backs Local Control Over Data Center Development: 'Communities That Will Live Alongside a Data center...'
